$Eli Lilly and Co (LLY.US)$ [Share Link: Eli Lilly diabetes ...

U.S. Food and Drug Administration (FDA) indicated on its website that supply shortages will continue throughout this year due to a rapid increase in demand for some doses of the diabetes treatment drug “manjaro (generic name tilzepatide)” by US pharmaceutical giant Eli Lilly.